🔗 Permalink

Inventor profile of:

Michael J. Keating

City:

Houston, Texas

Country:

United States

Published Applications:

Last publication date:

2019-02-07

Top Assignees for applications by Michael J. Keating

The entities that hold a legal rights for patent applications filed by inventor Keating Michael J.:

Board of Regents, The University of Texas System 13 Austin, TX United States
The Board of Regents of the University of Texas System 2 Austin, TX United States
Therm Med, LLC 1 Erie, PA United States
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEMS 1 Austin, TX United States
Board of Regents of the University of Texas System 1 Austin, TX United States

Recent patent applications by Keating Michael J.

Michael J. Keating from Houston, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2019-02-07

US20190041399A1

Physics

MEASURING CIRCULATING THERAPEUTIC ANTIBODY, ANTIGEN AND ANTIGEN/ANTIBODY COMPLEXES USING ELISA ASSAYS

#2 | 2018-02-15

US20180045736A1

Physics

Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays

#3 | 2016-03-10

US20160069902A1

Physics

MEASURING CIRCULATING THERAPEUTIC ANTIBODY, ANTIGEN AND ANTIGEN/ANTIBODY COMPLEXES USING ELISA ASSAYS

#4 | 2014-11-13

US20140335549A1

Physics

Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays

#5 | 2014-01-30

US20140030260A1

Human necessities

METHODS AND COMPOSITIONS TO ELIMINATE CHRONIC LYMPHOCYTIC LEUKEMIA AND OTHER HEMATOLOGIC MALIGNANT CELLS IN STROMAL MICROENVIRONMENT FOR CANCER THERAPY

#6 | 2014-01-09

US20140011215A1

Physics

Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays

#7 | 2013-01-03

US20130004977A1

Physics

Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays

#8 | 2012-06-14

US20120145891A1

Physics

Using plasma proteomic pattern for diagnosis, classification, prediction of response to therapy and clinical behavior, stratification of therapy, and monitoring disease in hematologic malignancies

#9 | 2012-05-03

US20120107846A1

Physics

Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays

#10 | 2011-09-29

US20110236994A1

Physics

Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays

#11 | 2010-09-02

US20100221761A1

Physics

Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays

#12 | 2010-05-18

US10251144

Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays

#13 | 2010-03-11

US20100063747A1

Physics

Using plasma proteomic pattern for diagnosis, classification, prediction of response to therapy and clinical behavior, stratification of therapy, and monitoring disease in hematologic malignancies

#14 | 2006-04-06

US20060073527A1

Physics

Using plasma proteomic pattern for diagnosis, classification, prediction of response to therapy and clinical behavior, stratification of therapy, and monitoring disease in hematologic malignancies

#15 | 2006-03-16

US20060058383A1

Human necessities

Propyl 3-bromo-2-oxopropionate and derivatives as novel anticancer agents

#16 | 2005-12-08

US20050273143A1

Human necessities

Systems and methods for combined RF-induced hyperthermia and radioimmunotherapy

#17 | 2005-11-10

US20050251234A1

Human necessities

Systems and methods for RF-induced hyperthermia using biological cells and nanoparticles as RF enhancer carriers

InventorID:

11949 ⎘